Evidence map›Paper›PMID 32514455›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2020

Stratification of gastric cancer risk using a deep neural network.

Hiroko Nakahira, Ryu Ishihara, Kazuharu Aoyama, Mitsuhiro Kono, Hiromu Fukuda, Yusaku Shimamoto, Kentaro Nakagawa, Masayasu Ohmori, Taro Iwatsubo, Hiroyoshi Iwagami and 12 more

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Hiroko NakahiraDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.ORCID https://orcid.org/0000-0003-2264-2963
Ryu IshiharaDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Kazuharu AoyamaAI Medical Service Inc Tokyo Japan.
Mitsuhiro KonoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Hiromu FukudaDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.ORCID https://orcid.org/0000-0002-1630-6288
Yusaku ShimamotoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Kentaro NakagawaDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Masayasu OhmoriDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Taro IwatsuboDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Hiroyoshi IwagamiDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Kenshi MatsunoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Shuntaro InoueDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Noriko MatsuuraDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.ORCID https://orcid.org/0000-0002-9322-9642
Satoki ShichijoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Akira MaekawaDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Takashi KanesakaDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Sachiko YamamotoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Yoji TakeuchiDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.ORCID https://orcid.org/0000-0003-3814-298X
Koji HigashinoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Noriya UedoDepartment of Gastrointestinal Oncology Osaka International Cancer Institute Osaka Japan.
Takashi MatsunagaDepartment of Medical Informatics Osaka International Cancer Institute Osaka Japan.
Tomohiro TadaAI Medical Service Inc Tokyo Japan.
Osaka International Cancer Institute · JPVeterinary Medical Center · JPOsaka International Cancer Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimStratifying gastric cancer (GC) risk and endoscopy findings in high-risk individuals may provide effective surveillance for GC. We developed a computerized image- analysis system for endoscopic images to stratify the risk of GC.

methodsThe system was trained using images taken during endoscopic examinations with non-magnified white-light imaging. Patients were classified as high-risk (patients with GC), moderate-risk (patients with current or past

resultsPerformance of the artificial intelligence (AI) system was evaluated by the prevalence of GC in each group using an independent validation dataset of patients who underwent endoscopic examination and

conclusionThe current AI system detected significant differences in the prevalence of GC among the low-, moderate-, and high-risk groups, suggesting its potential for stratifying GC risk.

Indexed as

artificial intelligenceconvolutional neural networkendoscopygastric cancer

Identifiers

PMID32514455
PMCPMC7273725
OpenAlexW2998166157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.